How Much Does Semaglutide Cost in 2026? Every Price, Every Option

Medically reviewed by Dr. Golsa Babapour, MD. Last updated April 2026.

I spent a week pulling pricing from every major source I could find: insurance formularies, telehealth platforms, Novo Nordisk's own programs, compounding pharmacies, and savings card fine print. What I found is that semaglutide pricing in 2026 is a maze, and most people are overpaying because they don't know all the options.

Here is every price point, organized so you can find the cheapest path for your situation.

:::takeaway

• Brand-name Ozempic (self-pay): $199 to $499/mo through NovoCare direct, or $1,028/mo list price
• Brand-name Wegovy: $199 to $399/mo through NovoCare direct, or $1,349/mo list price
• Compounded semaglutide: $99 to $175/mo through telehealth providers (availability uncertain after April 2026)
• With insurance: as low as $25/mo using savings cards; typical copay $25 to $150/mo
• Free option: Novo Nordisk patient assistance for income below 200% FPL
• Coming in 2027: 50% list price cut from Novo Nordisk, plus Medicare negotiated prices

:::

Quick Price Comparison

Before we get into the details, here is the big picture. These are real, current prices as of April 2026.

That range is enormous. The difference between the cheapest and most expensive option is more than a car payment every month. Let's break it down.

Brand-Name Ozempic Pricing

Ozempic is semaglutide made by Novo Nordisk, FDA-approved for type 2 diabetes and widely prescribed off-label for weight loss. Here is what it actually costs.

List price: approximately $1,028 per month. This is the sticker price almost nobody pays, but it is what shows up if you walk into a pharmacy without insurance and without any discount programs.

NovoCare direct pricing (Novo Nordisk's own program):

• $199/month for your first two fills (introductory offer)
• $349/month for 0.25mg, 0.5mg, and 1mg doses
• $499/month for the 2mg dose

This is a significant development. Novo Nordisk launched their direct-to-patient program to compete with compounding pharmacies, and it brings brand-name Ozempic into a price range that was previously only available through compounders.

With insurance: If your plan covers Ozempic (most do for diabetes, fewer for weight loss), your copay will typically fall between $25 and $150 per month depending on your formulary tier. Add the NovoCare savings card and you can push that down to $25 per month.

For more on navigating insurance coverage, check out our cost guide or see if your insurer is listed in our insurance coverage articles.

Brand-Name Wegovy Pricing

Wegovy is the same semaglutide molecule, but it is specifically FDA-approved for chronic weight management. It goes up to a 2.4mg dose (higher than Ozempic's max of 2mg), and in 2026, Novo Nordisk added two new options.

Wegovy Injections

• List price: approximately $1,349 per month
• NovoCare direct intro: $199/month for first two fills
• NovoCare direct standard: $349/month for maintenance injection doses

Wegovy Oral Pill (New in 2026)

Novo Nordisk launched oral semaglutide for weight loss under the Wegovy brand. This is a big deal for people who don't want weekly injections.

• Starter doses: $149/month
• Maintenance doses: $299/month

The pill requires fasting 30 minutes before eating and has slightly different absorption characteristics than the injection, but the convenience factor is real.

Wegovy HD 7.2mg

For patients who need a higher dose, the new Wegovy HD 7.2mg option runs $399/month through NovoCare direct. This is the highest available semaglutide dose and is typically reserved for patients who plateau on lower doses.

Compounded Semaglutide Pricing

Compounded semaglutide has been the budget option for the past two years. Telehealth providers partner with compounding pharmacies to offer custom-dosed semaglutide at a fraction of the brand-name price.

Here is what the major players charge:

For a full comparison of telehealth pricing, see our cheapest online GLP-1 providers guide.

The FDA Warning You Need to Know

Here is the critical context: the FDA removed semaglutide from the official drug shortage list. That triggers an enforcement deadline for compounding pharmacies in April 2026.

What this means in practice is still shaking out. Some compounders will stop producing semaglutide. Others are pursuing legal challenges. A few are pivoting to slightly different formulations.

:::warning

Compounded semaglutide availability is uncertain beyond April 2026. If you are currently using compounded semaglutide, talk to your provider about a backup plan. You may need to transition to brand-name options or explore insurance coverage. Do not wait until your supply runs out.

:::

If compounding does become unavailable, the NovoCare direct pricing ($199 to $349/mo) becomes the next cheapest self-pay option.

Semaglutide Cost with Insurance

Insurance coverage for GLP-1 weight loss medications has expanded significantly. Here is the current landscape.

Commercial insurance: About 43% of large employers now include GLP-1 coverage for obesity in their plans. Typical copays range from $25 to $150 per month. The NovoCare savings card can bring eligible patients down to $25 per month on top of insurance.

Medicare Part D: Currently covers Ozempic for type 2 diabetes. If your doctor prescribes Ozempic for diabetes and you happen to lose weight, Medicare will cover it.

Medicare obesity coverage: Wegovy coverage for obesity launches July 1, 2026. This is a massive expansion. Estimated copays will be around $50 per month for Medicare beneficiaries. If you are on Medicare and have been paying out of pocket, this date should be circled on your calendar.

Medicaid: Coverage varies dramatically by state. Some states cover GLP-1s for obesity, others only for diabetes, and a few don't cover them at all. Contact your state Medicaid office for specifics.

Not sure if you are covered? Take our quiz to get matched with providers that work with your insurance, or browse our telehealth provider directory to compare options.

Savings Programs and Discount Cards

Beyond insurance, there are several programs that can cut your costs.

NovoCare Savings Card

• $25/month with eligible commercial insurance
• Available for both Ozempic and Wegovy
• Not valid with Medicare, Medicaid, or other government insurance
• Apply at novocare.com or through your provider

NovoCare Patient Assistance Program (PAP)

• Free semaglutide for patients with income below 200% of the federal poverty level
• Covers both Ozempic and Wegovy
• Requires application and income verification
• This is a legitimate zero-cost option that many eligible patients don't know about

GoodRx and Discount Cards

• GoodRx prices: $199/month intro, $349/month standard (similar to NovoCare direct)
• Can sometimes beat pharmacy retail pricing
• Worth checking for price comparison, but NovoCare direct is usually comparable

Costco Pharmacy

• Competitive pricing with a Costco membership
• You do not need a Costco membership to use their pharmacy in most states
• Prices vary by location but are often among the lowest retail options

Novo Nordisk Multi-Month Subscription

• Commit to multiple months through NovoCare for up to $1,200/year in savings
• Works out to roughly $100/month off standard pricing
• Best for patients who know they will be on semaglutide long-term

Price by Dose

Semaglutide doses increase gradually during the titration period. Here is what you can expect to pay at each dose level through the most common channels.

Notice that insurance copays stay relatively flat regardless of dose, which is one of the biggest advantages of having coverage. With compounded and self-pay options, you pay more as your dose increases.

What Is Changing in 2026 and 2027

The semaglutide pricing landscape is shifting fast. Here are the dates and numbers that matter.

April 2026: Compounding Enforcement

The FDA's enforcement deadline for compounded semaglutide arrives this month. Expect some compounders to exit the market and prices at remaining compounders to potentially increase due to reduced competition.

July 1, 2026: Medicare Obesity Coverage

Medicare will begin covering Wegovy for obesity, not just diabetes. This opens up affordable access for millions of Medicare beneficiaries at estimated copays of about $50/month.

January 1, 2027: Novo Nordisk Price Cut

Novo Nordisk has announced a 50% list price reduction for semaglutide products effective January 1, 2027. This would bring Ozempic's list price down to roughly $514/month and Wegovy's to about $675/month.

2027: Medicare Negotiated Prices

Through the Inflation Reduction Act's drug price negotiation program, Medicare has negotiated the following prices:

• Ozempic: $274/month
• Wegovy: $385/month

These apply to Medicare Part D beneficiaries and represent substantial savings from current list prices.

Bottom Line: The Cheapest Way to Get Semaglutide Right Now

Let me cut through the complexity. Here is what I would do depending on your situation.

If you have commercial insurance that covers GLP-1s: Use your insurance plus the NovoCare savings card. You could pay as little as $25/month. This is the best deal available, period.

If you are uninsured or your plan does not cover GLP-1s: Compounded semaglutide at $99 to $175/month is still the cheapest option, but have a backup plan given the FDA situation. NovoCare direct at $199 to $349/month is your next best bet.

If your income is low: Apply for Novo Nordisk's patient assistance program. Free is hard to beat.

If you are on Medicare: Wait for July 1, 2026 if you can. Wegovy coverage at roughly $50/month is just around the corner. If you need semaglutide for diabetes right now, Ozempic is already covered under Part D.

If you want to save long-term: Consider the NovoCare multi-month subscription for up to $1,200/year in savings. And keep an eye on January 2027, when list prices drop 50%.

For more detailed information about semaglutide, including dosing, side effects, and clinical results, visit our semaglutide medication page.

:::info

Working with a provider matters. Semaglutide requires a prescription, and the right provider can help you navigate insurance coverage, savings programs, and dose adjustments. A good provider will also monitor for side effects and help you build the diet and exercise habits that make semaglutide most effective. Don't just chase the cheapest price; find a provider who will actually support your weight loss journey.

:::

Is the Cost Worth It? What the Clinical Data Shows

The STEP 1 trial showed that patients on semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks, compared to 2.4% with placebo. For context, that is roughly 37 pounds for a 250-pound person. The STEP 5 trial confirmed these results hold at two years.

Common side effects include nausea, constipation, and diarrhea, particularly during dose escalation. These are manageable for most patients and tend to improve over time. Semaglutide carries a black box warning about thyroid C-cell tumors based on animal studies, and should not be used by anyone with a history of pancreatitis or medullary thyroid carcinoma.

Alternatives in the GLP-1 class include Mounjaro and Zepbound (tirzepatide), which showed up to 22.5% weight loss in trials. Older options like Saxenda (liraglutide) and Contrave (naltrexone/bupropion) cost less but produce less weight loss. The newer oral GLP-1 Foundayo (orforglipron) is also now available starting at $149 per month.

Sources

1. Novo Nordisk. "NovoCare Savings Programs." novocare.com. Accessed April 2026.
2. FDA. "Drug Shortage Database: Semaglutide." fda.gov. Updated March 2026.
3. Centers for Medicare & Medicaid Services. "Medicare Part D Drug Price Negotiation Program." cms.gov. 2026.
4. KFF. "Employer Coverage of GLP-1 Medications for Obesity." kff.org. 2026 survey data.
5. GoodRx. "Ozempic Prices and Coupons." goodrx.com. Accessed April 2026.
6. Novo Nordisk. "Novo Nordisk Announces 50% List Price Reduction." Press release, 2026.
7. Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine. 2021;384(11):989-1002.